While Bioventus Inc has overperformed by 0.61%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BVS fell by -36.76%, with highs and lows ranging from $14.38 to $6.02, whereas the simple moving average fell by -30.36% in the last 200 days.
On July 07, 2025, Cantor Fitzgerald started tracking Bioventus Inc (NASDAQ: BVS) recommending Overweight. A report published by JP Morgan on December 17, 2024, Upgraded its rating to ‘Neutral’ for BVS. Canaccord Genuity also Upgraded BVS shares as ‘Buy’, setting a target price of $7 on the company’s shares in a report dated December 07, 2023. Craig Hallum August 09, 2023d the rating to Buy on August 09, 2023, and set its price target from $4 to $6. Craig Hallum November 22, 2022d its ‘Buy’ rating to ‘Hold’ for BVS, as published in its report on November 22, 2022. Canaccord Genuity also rated the stock as ‘Hold’.
Analysis of Bioventus Inc (BVS)
Further, the quarter-over-quarter decrease in sales is -4.31%, showing a negative trend in the upcoming months.
One of the most important indicators of Bioventus Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -19.79% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.89, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and BVS is recording 429.27K average volume. On a monthly basis, the volatility of the stock is set at 4.57%, whereas on a weekly basis, it is put at 4.57%, with a loss of -9.29% over the past seven days. Furthermore, long-term investors anticipate a median target price of $12.25, showing growth from the present price of $6.64, which can serve as yet another indication of whether BVS is worth investing in or should be passed over.
How Do You Analyze Bioventus Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 32.10%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 51.43% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
BVS shares are owned by institutional investors to the tune of 51.43% at present.
